Direct oral anticoagulants (DOACs) including rivaroxaban and apixaban are first-line anticoagulation for PE in eligible patients. Minimum 3 months recommended after first PE; extended treatment considered based on individual recurrence risk assessment.

A structured programme of gradually increasing walking distance and intensity following PE. Early ambulation once anticoagulation is established helps restore exercise capacity and reduces deconditioning.

Structured pulmonary rehabilitation combining aerobic exercise, breathing exercises, and education for PE recovery. Growing evidence supports its use to restore lung function and exercise capacity post-PE.

Graduated compression stockings for leg symptoms following DVT associated with PE. Help reduce leg swelling, pain, and post-thrombotic syndrome risk.

Psychological support and anxiety management techniques for the significant psychological impact of PE. Anxiety, fear of recurrence, and depression are common after PE and significantly impact quality of life and recovery.

Stopping smoking to reduce recurrence risk and cardiovascular complications after PE. Smoking is a significant risk factor for recurrent venous thromboembolism and cardiovascular disease.

Omega-3 fatty acid supplementation as an adjunct to recovery after PE. Emerging evidence suggests anti-inflammatory properties may help mitigate thromboembolic risk as part of a comprehensive recovery approach.

Correcting vitamin D deficiency as part of PE recovery. Vitamin D deficiency has been linked to increased thromboembolic risk and may impair recovery.